These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12861987)

  • 21. Therapeutic cancer vaccines on trial.
    Reichert JM; Paquette C
    Nat Biotechnol; 2002 Jul; 20(7):659-63. PubMed ID: 12089545
    [No Abstract]   [Full Text] [Related]  

  • 22. Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses.
    Houghton M
    Immunol Rev; 2011 Jan; 239(1):99-108. PubMed ID: 21198667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Towards a bivalent prophylactic vaccine against hepatitis B and C viruses?].
    Beaumont E; Roingeard P
    Med Sci (Paris); 2014 Jan; 30(1):33-5. PubMed ID: 24472456
    [No Abstract]   [Full Text] [Related]  

  • 24. DNA vaccines for hepatitis C virus.
    Brinster C; Inchauspé G
    Intervirology; 2001; 44(2-3):143-53. PubMed ID: 11509875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Various forms of hepatitis and their prevention].
    Reesink HW
    Ned Tijdschr Geneeskd; 1987 May; 131(19):812-4. PubMed ID: 3108679
    [No Abstract]   [Full Text] [Related]  

  • 26. Update on vaccines for solid tumors.
    Gajewski TF
    Clin Adv Hematol Oncol; 2004 Mar; 2(3):158-9. PubMed ID: 16166944
    [No Abstract]   [Full Text] [Related]  

  • 27. [Viral hepatitis].
    Blond B
    Soins; 2009 Dec; (741):59-60. PubMed ID: 20067051
    [No Abstract]   [Full Text] [Related]  

  • 28. Interscience Conference on Antimicrobial Agents and Chemotherapy--45th Annual Meeting. Vaccines, novel technologies and adjuvants.
    Searle B
    IDrugs; 2006 Feb; 9(2):71-3. PubMed ID: 16523388
    [No Abstract]   [Full Text] [Related]  

  • 29. Prospects for prophylactic and therapeutic vaccines against hepatitis C virus.
    Feinstone SM; Hu DJ; Major ME
    Clin Infect Dis; 2012 Jul; 55 Suppl 1():S25-32. PubMed ID: 22715210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized clinical studies of anti-tumor vaccination: state of the art in 2008.
    Fournier P; Schirrmacher V
    Expert Rev Vaccines; 2009 Jan; 8(1):51-66. PubMed ID: 19093773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular aspects of the antiviral response against hepatitis C virus implicated in vaccines development].
    Llanes MS; Palacios NS; Piccione M; Ruiz MG; Layana C
    Enferm Infecc Microbiol Clin; 2015 Apr; 33(4):273-80. PubMed ID: 24529681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [S3 guideline hepatitis C addendum].
    Sarrazin C; Berg T; Buggisch P; Dollinger MM; Hinrichsen H; Hofer H; Hüppe D; Manns MP; Mauss S; Petersen J; Simon KG; van Thiel I; Wedemeyer H; Zeuzem S
    Z Gastroenterol; 2015 Apr; 53(4):320-34. PubMed ID: 25867048
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis C and hepatitis E vaccines: research update.
    Locarnini S
    Med J Malaysia; 2005 Jul; 60 Suppl B():116-24. PubMed ID: 16108191
    [No Abstract]   [Full Text] [Related]  

  • 34. Cancer Vaccine Collaborative 2002: opening address.
    Old LJ
    Cancer Immun; 2003 Feb; 3 Suppl 1():1. PubMed ID: 12747742
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus.
    Gentile I; Zappulo E; Buonomo AR; Borgia G
    Expert Rev Anti Infect Ther; 2014 Jul; 12(7):775-82. PubMed ID: 24840817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Vaccines & Immunotherapeutics: News.
    Hum Vaccin Immunother; 2017 May; 13(5):968-969. PubMed ID: 28509656
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasmid DNA and viral vector-based vaccines for the treatment of cancer.
    Anderson RJ; Schneider J
    Vaccine; 2007 Sep; 25 Suppl 2():B24-34. PubMed ID: 17698262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contamination by hepatitis C in a haemodialysis center: preventive measures.
    Guiserix J
    Nephron; 1996; 72(4):721-2. PubMed ID: 8730457
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatitis C vaccine: supply and demand.
    Inchauspé G; Honnet G; Bonnefoy JY; Nicosia A; Strickland GT
    Lancet Infect Dis; 2008 Dec; 8(12):739-40. PubMed ID: 19022189
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatitis B vaccines.
    Troisi CL; Hollinger FB
    Prog Liver Dis; 1990; 9():405-42. PubMed ID: 2156306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.